Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.73M Buy
22,751
+2,407
+12% +$518K 0.59% 41
2026
Q1
$4.42M Buy
20,344
+907
+5% +$201K 0.47% 47
2025
Q4
$4.44M Sell
19,437
-228
-1% -$51.9K 0.44% 51
2025
Q3
$4.55M Sell
19,665
-210
-1% -$42.8K 0.45% 52
2025
Q2
$3.69M Sell
19,875
-515
-3% -$95.7K 0.37% 54
2025
Q1
$4.27M Buy
20,390
+106
+0.5% +$20.6K 0.44% 54
2024
Q4
$3.6M Sell
20,284
-340
-2% -$62.5K 0.37% 56
2024
Q3
$4.07M Buy
20,624
+43
+0.2% +$8.03K 0.4% 55
2024
Q2
$3.53M Buy
20,581
+15
+0.1% +$2.48K 0.38% 59
2024
Q1
$3.74M Buy
20,566
+196
+1% +$33.8K 0.4% 57
2023
Q4
$3.16M Buy
20,370
+496
+2% +$72.3K 0.35% 60
2023
Q3
$2.96M Sell
19,874
-60
-0.3% -$8.81K 0.36% 58
2023
Q2
$2.69M Sell
19,934
-55
-0.3% -$8.06K 0.31% 66
2023
Q1
$3.19M Sell
19,989
-200
-1% -$30.6K 0.39% 58
2022
Q4
$3.26M Sell
20,189
-84
-0.4% -$12.9K 0.42% 57
2022
Q3
$2.72M Sell
20,273
-810
-4% -$116K 0.38% 60
2022
Q2
$3.23M Sell
21,083
-315
-1% -$48.1K 0.42% 57
2022
Q1
$3.47M Buy
21,398
+1,505
+8% +$219K 0.4% 57
2021
Q4
$2.69M Sell
19,893
-10
-0.1% -$1.18K 0.28% 66
2021
Q3
$2.15M Buy
19,903
+1,110
+6% +$127K 0.25% 67
2021
Q2
$2.12M Sell
18,793
-777
-4% -$87.5K 0.25% 66
2021
Q1
$2.12M Buy
19,570
+6,814
+53% +$729K 0.27% 65
2020
Q4
$1.37M Buy
12,756
+2,514
+25% +$242K 0.18% 73
2020
Q3
$897K Buy
10,242
+550
+6% +$51.8K 0.15% 78
2020
Q2
$951K Sell
9,692
-255
-3% -$22.5K 0.17% 71
2020
Q1
$758K Buy
9,947
+775
+8% +$66K 0.16% 73
2019
Q4
$812K Sell
9,172
-51
-0.6% -$4.23K 0.15% 75
2019
Q3
$698K Buy
9,223
+25
+0.3% +$1.71K 0.13% 77
2019
Q2
$669K Buy
9,198
+1,760
+24% +$138K 0.13% 75
2019
Q1
$599K Sell
7,438
-850
-10% -$69.5K 0.13% 79
2018
Q4
$764K Buy
8,288
+640
+8% +$56.3K 0.19% 71
2018
Q3
$724K Sell
7,648
-217
-3% -$20.6K 0.16% 77
2018
Q2
$729K Buy
7,865
+1,193
+18% +$117K 0.17% 79
2018
Q1
$631K Sell
6,672
-265
-4% -$29.1K 0.16% 85
2017
Q4
$671K Sell
6,937
-115
-2% -$10.8K 0.17% 84
2017
Q3
$627K Hold
7,052
0.17% 86
2017
Q2
$511K Sell
7,052
-1,100
-13% -$74K 0.14% 90
2017
Q1
$532K Buy
8,152
+175
+2% +$11K 0.16% 88
2016
Q4
$499K Sell
7,977
-1,712
-18% -$105K 0.15% 88
2016
Q3
$611K Sell
9,689
-300
-3% -$19.4K 0.19% 85
2016
Q2
$619K Sell
9,989
-200
-2% -$12.2K 0.19% 74
2016
Q1
$582K Sell
10,189
-3,497
-26% -$195K 0.19% 82
2015
Q4
$810K Buy
13,686
+101
+0.7% +$5.82K 0.27% 70
2015
Q3
$739K Sell
13,585
-144
-1% -$9.37K 0.26% 73
2015
Q2
$922K Sell
13,729
-2,033
-13% -$133K 0.32% 67
2015
Q1
$923K Buy
15,762
+1,532
+11% +$92.6K 0.31% 70
2014
Q4
$931K Buy
14,230
+2,450
+21% +$154K 0.32% 67
2014
Q3
$681K Sell
11,780
-1,037
-8% -$57.6K 0.26% 69
2014
Q2
$724K Sell
12,817
-240
-2% -$12.6K 0.28% 69
2014
Q1
$671K Sell
13,057
-400
-3% -$20.2K 0.27% 69
2013
Q4
$711K Sell
13,457
-160
-1% -$7.86K 0.29% 67
2013
Q3
$609K Sell
13,617
-893
-6% -$39.6K 0.27% 69
2013
Q2
$600K Buy
+14,510
New +$635K 0.28% 67

Other funds holding ABBV

Bath Savings Trust's ABBV Position: Q2 2026 in Review

Bath Savings Trust increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $518K and bringing the position to 22,751 shares worth $5.73M. The position accounts for 0.59% of the portfolio, ranked #41.

Bath Savings Trust first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bath Savings Trust held 22,751 shares of AbbVie worth $5.73M as of Q2 2026.
  • Bath Savings Trust bought 2,407 AbbVie shares in Q2 2026, an estimated $518K.
  • AbbVie made up 0.59% of Bath Savings Trust's portfolio in Q2 2026, its #41 holding.
  • Bath Savings Trust first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bath Savings Trust's 13F filing for Q2 2026, filed 9 Jul 2026.